Researchers say it’s a sign that more targeted therapies are needed for the vulnerable patient population.
Inhibition of STAT3 signaling may improve survival in those with H3.3G34R/V mutant gliomas, animal studies suggest.
In cell and mouse models, metformin suppressed tumor growth in group A posterior fossa ependymomas.
New study reveals the location and behavior of specific cells behind lung fibrosis.
A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.